FOXP3 and melanoma: We compared the CTLA-4 protein expression in Tregs (CD4+ Foxp3+) from these patients to five ipilimumab-treated melanoma patients, since they also have disruption of the CTLA-4 pathway and can experience a wide array of autoimmune complications.